Target Audience
At the end of the Conference, the participants will be able to:
Opening Remarks | ||||
8:00 | 8:05 | Dr. Al Khodor Dr. Maccalli Sidra Medicine, Qatar |
Welcome notes | |
8:05 | 8:10 | Prof. Johnny Awwad Chair of Women’s Services Sidra Medicine, Qatar |
Precision Medicine in Women’ Health at Sidra Medicine, Qatar | |
8:10 | 8:20 | Prof. Duygu Ozel Demiralp Vice-Rector Dokuz Eylul University, Turkey |
Precision Medicine at Dokuz Eylul University, Turkey | |
Session 1: Precision Medicine in Women’s Health Chairs: Dr. Hala Abdullahi and Dr. Suruchi Mohan |
||||
8:20 | 8:45 | Speaker - Main talk | Dr. Najat Khenyab Women's Wellness and Research Center, Hamad Medical Corporation, Qatar |
National efforts for improving maternal health |
8:45 | 9:10 | Speaker - Main talk | Dr. Nahla Afifi Qatar Biobank, Qatar |
Role of QBB in the implementation of Precision Medicine research in Qatar |
9:10 | 9:35 | Speaker - Main talk | Dr. Matteo Avella Sidra Medicine, Qatar |
The molecular mechanisms of human fertilization and tools for personalized treatments in IVF |
9:35 | 10:00 | Speaker - Main talk | Dr. Annalisa Terranegra Sidra Medicine, Qatar |
Precision nutrition approach to female reproductive health: the case of PN-ART and Omouma studies |
10:00 | 10:25 | Speaker - Main talk | Dr. Aisha Yousef Sidra Medicine, Qatar |
Robotics surgery in the era of Precision Medicine |
10:25 | 10:50 | Break and Poster viewing | ||
Session 2: Women's mental Health Chairs: Dr. Sawssan Ahmed and Dr. Meritxell Espino Guarch |
||||
10:50 | 11:15 | Speaker - Main talk | Dr. Zainab Imam Sidra Medicine, Qatar |
Women and the Workplace: Tips and Tools for Inspiring Psychological Well-Being |
11:15 | 12:00 | Workshop | Dr. Sawssan Ahmed Ms. Danah Ghadban Sidra Medicine, Qatar |
Women wellness in the workplace |
12:00 | 13:00 | Lunch Break and networking | ||
Young female investigators’ session Chairs: Dr. Moza al Kuwari and Dr. Kholoud Al Shafei |
||||
13:00 | 13:30 | Oral Abstract Presentations | ||
Session 3: Precision Medicine Cancer Chairs: Dr. Hadi Abu Rasheed and Dr. Sahar Da’as |
||||
13:30 | 13:55 | Speaker - Main talk | Dr. Salha Bujassoum National Center for Cancer Care & Research, Hamad Medical Corporation, Qatar |
The role of Precision Medicine to advance diagnosis and therapy of breast cancer |
13:55 | 14:20 | Speaker - Main talk | Dr. Hind Hamad Elmalik National Center for Cancer Care & Research, Hamad Medical Corporation, Qatar |
Ovarian cancer management during era of Precision Medicine |
14:20 | 15:05 | Keynote Speaker | Professor Lisa Butterfield Parker Institute for Cancer Immunotherapy & University of California, USA |
The Impact of cancer immunotherapy |
15:05 | 15:30 | Speaker - Main talk | Dr. Osman Ortashi Sidra Medicine, Qatar |
Cervical cancer and the importance of early screening and prevention |
15:30 | 15:45 | Speaker - Main talk | Dr. Hadi Abu Rasheed Qatar Cancer Society, Qatar |
The cancer civil society organizations' Role in personalised healthcare and equity in women’s cancer |
15:45 | 16:15 | Break and Poster viewing | ||
Panel Discussion: “ Women in Science: successful career stories and challenges” Chair: Dr. Amel Hassan |
||||
16:15 | 17:00 | Prof. Lisa Butterfield Dr. Aisha Yousef Dr. Nahla Afifi Dr. Sawssan Ahmed Ms. Wafa Alsaadi |
||
17:00 | 17:10 | Closing remarks | Dr. Al Khodor/Dr. Maccalli |
"This activity is an Accredited Group Learning Activity Category X as defined by the Ministry of Public Health’s Department of Healthcare Professions-Accreditation Section (DHP-AS) and is approved for a maximum of 6.50 hours."
In support of improving patient care, Sidra Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The Scientific Planning Committee has reviewed all disclosed relevant relationships of speakers, moderators, facilitators, and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest. |
|
|